Finished product reference
Covid-19 Vaccine, Whole Virion, Inactivated, Vero Cell-derived
Injection · Parenteral · 2 dose
- List code
- 52823
- Pharmacologic class
- COVID-19 vaccine (whole-virion inactivated, Vero cell-derived)
What it is and how it works
Contains SARS-CoV-2 grown in Vero cell culture, chemically inactivated (for example with beta-propiolactone) and adsorbed on aluminium hydroxide adjuvant. The inactivated virus presents multiple viral antigens, inducing neutralising antibodies against SARS-CoV-2.
Indications
Active immunisation to prevent COVID-19 in the age groups specified for each product.
Dosage and administration (summary)
Given by intramuscular injection, usually as a two-dose primary series with boosters, according to the national immunisation protocol.
Contraindications
Severe allergic reaction to a previous dose or to any component of the vaccine.
Warnings and precautions
Appropriate treatment for anaphylaxis must be available and recipients observed after vaccination. Postpone in acute severe febrile illness; use with caution in thrombocytopenia or coagulation disorders. Immunocompromised individuals may have a reduced immune response.
Pregnancy
May be used in pregnancy where national guidance recommends it after benefit–risk assessment.
Storage and supply
Store refrigerated at 2–8 °C; do not freeze; protect from light.
Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.
Other presentations of the same active ingredient
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.